GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
2.390
+0.200 (9.13%)
At close: Feb 6, 2026, 4:00 PM EST
2.460
+0.070 (2.93%)
After-hours: Feb 6, 2026, 7:58 PM EST
GRI Bio Market Cap
GRI Bio has a market cap or net worth of $3.45 million as of February 6, 2026. Its market cap has decreased by -43.62% in one year.
Market Cap
3.45M
Enterprise Value
-4.70M
1-Year Change
-43.62%
Ranking
Category
Stock Price
$2.39
Market Cap Chart
Since April 24, 2023, GRI Bio's market cap has decreased from $25.29M to $3.45M, a decrease of -86.34%. That is a compound annual growth rate of -50.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 3.45M | 38.26% |
| Dec 31, 2025 | 2.50M | -66.25% |
| Dec 31, 2024 | 7.40M | 326.73% |
| Dec 29, 2023 | 1.73M | -93.14% |
| Apr 24, 2023 | 25.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enveric Biosciences | 3.66M |
| Aspire Biopharma Holdings | 3.55M |
| Indaptus Therapeutics | 3.48M |
| XORTX Therapeutics | 3.46M |
| Galmed Pharmaceuticals | 3.26M |
| Lyra Therapeutics | 3.14M |
| Psyence Biomedical | 2.95M |
| Scinai Immunotherapeutics | 2.94M |